Shares of health insurer Centene are falling after a report from competitor Elevance Health highlighted weaker margins, raising investor concerns about rising medical costs across the managed care sector.
The advanced nuclear fuel company cut its fundraising target to $150 million and its valuation to $2.4 billion in a revised regulatory filing ahead of its New York Stock Exchange debut.
Shares of CAVA Group gained after Morgan Stanley upgraded the restaurant stock to 'Overweight,' citing a favorable entry point after a recent price decline and confidence in the company's long-term fundamentals.
Investor Michael Burry has dismissed a reported $53 billion takeover bid for PayPal from Stripe and Advent International, arguing the $60.50 per share offer significantly undervalues the payments company and is merely an 'opening bid.'
Shares of Ernexa Therapeutics (NASDAQ:ERNA) surged after the company reported that an independent study validated the effectiveness of its lead cell therapy candidate, ERNA-101, in ovarian cancer models.
The investment bank reported a significant rise in second-quarter profit, with net income soaring as a record-breaking environment for mergers and acquisitions boosted advisory fees.
Canadian stock futures dipped Wednesday morning as investors paused ahead of a key interest rate announcement from the Bank of Canada, weighing a recent commodity rally against renewed inflation concerns.
The packaged food giant projected fiscal 2027 earnings below analyst estimates and announced a dividend cut, pointing to persistent commodity inflation and cautious consumer spending.
Oppenheimer has lowered its rating on IBM to 'Perform' and removed its $350 price target, citing the company's disappointing preliminary Q2 results which missed estimates across all segments.
